Skip to main content
Clinical Trials/NCT01383915
NCT01383915
Active, not recruiting
Not Applicable

Characterizing the Clinical Risk State for Bipolar Disorder in Adolescents

Northwell Health1 site in 1 country402 target enrollmentSeptember 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bipolar Disorder
Sponsor
Northwell Health
Enrollment
402
Locations
1
Primary Endpoint
Number of subjects with development of a bipolar or schizophrenia disorder
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

Aim: The purpose of the study is to characterize the at-risk phases preceding a first episode of bipolar disorder and of schizophrenia, and to identify clinical and biological predictors of the disease development.

Hypothesis a: Over 6-24 months, 25% of at-risk youth will develop the full manifestations of Bipolar Disorder (BPD) or schizophrenia.

Hypothesis b: The symptoms utilized for characterizing the at-risk phase of BPD will differentiate between individuals developing BPD and schizophrenia.

Detailed Description

Prospective, naturalistic, cohort study aiming to characterizing the bipolar and psychotic prodrome thoroughly with a variety of clinical and biological measures.

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
December 31, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christoph U. Correll, MD

Principal Investigator

Northwell Health

Eligibility Criteria

Inclusion Criteria

  • Age: 12-18 years;
  • Sex: male or female;
  • Race/ethnicity: no restrictions;
  • Definite or suspected chart diagnosis of BP-II, BP-NOS, cyclothymia, MDD, depressive disorder NOS, dysthymia or mood disorder NOS, schizophrenifiorm disorder or psychotic disorder NOS;
  • Subject and parent (if subject\<18) willing and able to provide written, informed consent/assent.

Exclusion Criteria

  • Estimated Premorbid IQ \< 70;
  • Meets DSM-IV criteria for BP-I or schizophrenia, pervasive developmental disorder, autism spectrum disorders, current substance dependence;
  • History of medical condition known to affect the brain;
  • current group home affiliation.

Outcomes

Primary Outcomes

Number of subjects with development of a bipolar or schizophrenia disorder

Time Frame: within 60 months

Diagnostic conversion

Secondary Outcomes

  • Psychopathology(within 60 months)

Study Sites (1)

Loading locations...

Similar Trials